Comparison of long-term outcomes of 50 and 100 mg rt-PA in the management of acute pulmonary thromboembolism.

Elif Yılmazel Uçar Ömer ArazBugra KergetNafiye YilmazMetin AkgunLeyla Saglam

Published in: The clinical respiratory journal (2017)

Our results suggest that both doses of rt-PA have similar efficacy. The high mortality rate in the 50 mg group may have resulted from patient selection.

Keyphrases

liver failure
pulmonary hypertension
case report
respiratory failure
cardiovascular events
drug induced
aortic dissection
risk factors
hepatitis b virus